Report
Wim Hoste

Akzo Nobel Painting the future is a gradual work

We have updated our earnings model following slightly better than expected 1Q24 results (with a 4% beat on adjusted EBITDA level), with very limited changes though that have been made to our 2024/2025 adjusted EBITDA forecast (upped by <1%). The past few years have been impacted by COVID-disruptions (which have given a temporary boost to Deco) and a fierce inflationary cycle, of which the dust has been settling in recent quarters with selling prices adjusted and now up about a quarter on a two year stack. Going forward, it looks like efficiency improvements and footprint optimization will be amongst the key drivers to further improve profitability. We put some faith in the execution of the plans but on the back of the limited structural growth of the industry, we consider Akzo's valuation to be about fair and reiterate our Hold rating and € 75 target price.
Underlying
Akzo Nobel N.V.

Akzo Nobel N.V. is a holding company. Through its subsidiaries, Co. is engaged in the production and marketing of paints, coatings and specialty chemicals. Co. has three segments: Decorative Paints, which supplies products for the professional and do-it-yourself markets, including paints, lacquers and varnishes, as well as products for surface preparation; Performance Coatings, which is divided into the following businesses: Automotive and Aerospace Coatings, Industrial Coatings, Marine and Protective Coatings, and Powder Coatings; and Specialty Chemicals, which are used in products such as ice cream, soups, disinfectants, plastics, soaps, detergents, cosmetics, paper and asphalt.

Provider
KBC Securities
KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Analysts
Wim Hoste

Other Reports on these Companies
Other Reports from KBC Securities
Hilde Van Boxstael ... (+6)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Michiel Declercq
  • Sharad Kumar S.P
  • Wim Hoste
  • Wim Lewi

ResearchPool Subscriptions

Get the most out of your insights

Get in touch